COMISII CNAS
- Comisia de Poliartrita Reumatoida, Artropatie Psoriazica, Artrita Idiopatica Juvenila, Spondilita anchilopoietica aproba urmatoarele medicamente:
- RITUXIMABUM; ETANERCEPTUM; INFLIXIMABUM; ADALIMUMABUM
- Comisia de Boli oncologice (leucemii si tumori maligne solide) si monitorizarea activa a terapiilor specifice oncologice
- TRABECTEDINUM; PEMETREXEDUM; FLUDARABINUM; RITUXIMABUM; TRASTUZUMABUM; CETUXIMABUM; BEVACIZUMABUM; IMATINIBUM; ERLOTINIBUM; OFATUMUMAB; RUXOLITINIBUM, SUNITINIBUM; DECITABINUM, SORAFENIBUM, DASATINIBUM; NILOTINIBUM; BORTEZOMIBUM; CLOFARABINUM; NELARABINUM
- Comisia de Hepatite cronice virale B,C,D si ciroze hepatice B,C,D
- RIBAVIRINUM; LAMIVUDINUM; ADEFOVIRUM DIPIVOXILUM; ENTECAVIRUM; INTERFERONUM ALFA 2A; INTERFERONUM ALFA 2B; PEGINTERFERON ALFA 2B; PEGINTERFERON ALFA 2A
- Comisia pentru Boala inflamatorie cronica intestinala
- INFLIXIMABUM; ADALIMUMABUM
- Comisia pentru Boala Gaucher
- IMIGLUCERASUM
- Comisia de Boli endocrine
- PEGVISOMANTUM; OCTREOTIDUM; LANREOTIDUM
- Comisia pentru Tulburari de nutritie si metabolism (obezitate)
- ORLISTATUM
- Comisia pentru Psoriazis cronic sever
- ETANERCEPTUM; INFLIXIMABUM; ADALIMUMABUM
- Comisia pentru Infertilitate
- FOLLITROPINUM ALFA; FOLLITROPINUM BETA; LUTROPINUM ALFA
- Comisia pentru Hemofilie - Talasemie P6.1
- DEFERASIROXUM